Goat Polyclonal Anti-Rab9 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Products
Calcitonin gene-related peptide 1 (alpha-CGRP), guinea pig anti canine/mouse/rat, polyclonal.
| Applications | ELISA |
| Reactivities | Canine, Mouse, Rat |
Claudin 1 (CLDN1) rabbit polyclonal antibody, Purified
| Applications | IHC |
| Reactivities | Canine, Human, Mouse, Rat |
Claudin 1 (CLDN1) rabbit polyclonal antibody, Purified
| Applications | IHC |
| Reactivities | Canine, Human, Mouse, Rat |
Rabbit polyclonal anti canine / mouse / porcine / rat Peptide YY
| Applications | ELISA |
| Reactivities | Canine, Mouse, Porcine, Rat |
Rabbit Polyclonal HDAC7 [p Ser318] Antibody
| Applications | WB |
| Reactivities | Human, Bovine, Canine, Equine, Primate, Zebrafish |
Rabbit Polyclonal HDAC7 [p Ser448] Antibody
| Applications | WB |
| Reactivities | Human, Rat, Bovine, Canine, Equine, Primate |
Rabbit Polyclonal UVRAG Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat, Canine, Chicken, Primate |
Rabbit Polyclonal Spi-B Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Bovine, Canine, Equine, Primate |
Rabbit Polyclonal VDAC2/3 Antibody
| Applications | WB |
| Reactivities | Human, Bovine, Canine, Feline, Primate |
Canine IgA (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in immunocytochemical and immunohistochemical staining of IgA at the cellular and subcellular level of appropriately treated cell and tissue substrates; to demonstrate circulating IgA antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using a reference antibody of dog origin known to be of the IgA isotype in the middle layer of the indirect test procedure. Antisera to IgA do not discriminate between serum IgA (monomeric and dimeric) and higher molecular forms such as secretory IgA. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/20 and 1/80, depending on the method used. |
| Reactivities | Canine |
| Conjugation | FITC |
Fibrinogen goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IP |
| Reactivities | Canine |
Canine IgG (H+L chain) goat polyclonal antibody, FITC
| Applications | Can be used to identify and measure IgG, antigen or antibody, at the cellular and subcellular level by immunofluorescence staining of appropriately treated cell and tissue substrates, and to demonstrate circulating antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen or immune complex using a reference antibody of dog origin in the middle layer of the indirect test procedure. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/20 and 1/120. |
| Reactivities | Canine |
| Conjugation | FITC |
Canine IgG (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in immunocytochemical and immunohistochemical staining of IgG at the cellular and subcellular level of appropriately treated cell and tissue substrates; to demonstrate circulating IgG antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using a reference antibody of dog origin known to be of the IgG isotype in the middle layer of the indirect test procedure. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/15 and 1/60, depending on the method used. |
| Reactivities | Canine |
| Conjugation | FITC |
活动过滤器
优化搜索结果
Target Symbol
- CALNEXIN (5)
- GAPDH (5)
- RAB27A (5)
- ATAXIN 3 (4)
- CHM (4)
- ERP57 (4)
- GJA1 (4)
- HCRT (4)
- ALPHA TUBULIN (3)
- CALCA (3)
- HIF-1 ALPHA (3)
- MLN (3)
- PYY (3)
- RAB11A (3)
- RAB5 (3)
- SAE1 (3)
- TJP1 (3)
- BMI1 (2)
- CASPASE 3 (2)
- CASPASE 9 (2)
- CATHEPSIN D (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- CDC27 (2)
- CLDN1 (2)
- DMTF1 (2)
- E CADHERIN (2)
- EPM2AIP1 (2)
- FBXO9 (2)
- FZD9 (2)
- GAD67 (2)
- GAP43 (2)
- GFAP (2)
- HDAC7A (2)
- HDAC9 (2)
- IDH1 (2)
- KCNIP3 (2)
- KIT (2)
- MAPK9 (2)
- MAPKAPK5 (2)
- NQO1 (2)
- P53 (2)
- POU2AF1 (2)
- POU2F2 (2)
- PPARG (2)
- PSMB4 (2)
- RAB14 (2)
- RAB1B (2)
- RAB7 (2)
- RAB9A (2)
- ROBO1 (2)
- RPS6KA1 (2)
- SNCA (2)
- SOD2 (2)
- TIMP3 (2)
- TNNI3 (2)
- UCHL1 (2)
- 14-3-3 SIGMA (1)
- 5HT7 RECEPTOR (1)
- ABCB1 (1)
- ACADVL (1)
- ACTIVIN RECEPTOR TYPE IA (1)
- AGGRECAN (1)
- AGRP (1)
- AIF (1)
- AIRE (1)
- ALB (1)
- ALBUMIN (1)
- ALDH5A1 (1)
- ALDH6A1 (1)
- ALG2 (1)
- AMPD1 (1)
- ANGIOMOTIN LIKE 1 (1)
- ANKRD32 (1)
- ANNEXIN A1 (1)
- AOC2 (1)
- AP3D1 (1)
- APG12 (1)
- APOLIPOPROTEIN H (1)
- APP (1)
- ARHGEF11 (1)
- ATF6 (1)
- ATG16L1 (1)
- ATP6AP1 (1)
- AXIN1 (1)
- BAG5 (1)
- BAG6 (1)
- BAX (1)
- BBS4 (1)
- BBS7 (1)
- BCL2 (1)
- BCOR (1)
- BECLIN 1 (1)
- BEND5 (1)
- BETA ACTIN (1)
- BETA ARRESTIN 2 (1)
- BETA CATENIN (1)
- BETA V TUBULIN (1)
- BLBP (1)
Applications
Antibody Hosts
Conjugates
Assay Types
Families
- Druggable Genome (187)
- Transmembrane (65)
- Transcription Factors (43)
- ES Cell Differentiation/IPS (28)
- Secreted Protein (20)
- Stem cell - Pluripotency (12)
- Protein Kinase (11)
- Protease (10)
- GPCR (5)
- Adult stem cells (4)
- Ion Channels: Other (4)
- Phosphatase (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (4)
- Embryonic stem cells (3)
- Induced pluripotent stem cells (3)
- Cancer stem cells (2)
- Ion Channels: Cys-loop Receptors (2)
- Ion Channels: Potassium (2)
- Ion Channels: Transient receptor potential (2)
- Nuclear Hormone Receptor (2)
- P450 (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
Pathways
- Pathways in cancer (26)
- Metabolic pathways (18)
- Endocytosis (15)
- Amyotrophic lateral sclerosis (ALS) (14)
- MAPK signaling pathway (12)
- Adherens junction (11)
- Alzheimer's disease (11)
- Antigen processing and presentation (11)
- Apoptosis (11)
- Colorectal cancer (11)
- Endometrial cancer (11)
- Focal adhesion (11)
- Gap junction (11)
- Cell adhesion molecules (CAMs) (10)
- Huntington's disease (10)
- Pancreatic cancer (10)
- Pathogenic Escherichia coli infection (10)
- Prostate cancer (10)
- Bladder cancer (9)
- p53 signaling pathway (9)
- Calcium signaling pathway (8)
- Cytokine-cytokine receptor interaction (8)
- Non-small cell lung cancer (8)
- T cell receptor signaling pathway (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Neuroactive ligand-receptor interaction (7)
- Renal cell carcinoma (7)
- VEGF signaling pathway (7)
- Wnt signaling pathway (7)
- Cell cycle (6)
- Epithelial cell signaling in Helicobacter pylori infection (6)
- Lysosome (6)
- Melanoma (6)
- Natural killer cell mediated cytotoxicity (6)
- Neurotrophin signaling pathway (6)
- Parkinson's disease (6)
- Small cell lung cancer (6)
- Thyroid cancer (6)
- Tight junction (6)
- Type I diabetes mellitus (6)
- Viral myocarditis (6)
- mTOR signaling pathway (6)
- Glycolysis / Gluconeogenesis (5)
- Hematopoietic cell lineage (5)
- Insulin signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Primary immunodeficiency (5)
- Progesterone-mediated oocyte maturation (5)
- Toll-like receptor signaling pathway (5)
- Acute myeloid leukemia (4)
- Adipocytokine signaling pathway (4)
- Alanine (4)
- B cell receptor signaling pathway (4)
- Basal cell carcinoma (4)
- Chemokine signaling pathway (4)
- Glioma (4)
- GnRH signaling pathway (4)
- Jak-STAT signaling pathway (4)
- Oocyte meiosis (4)
- RIG-I-like receptor signaling pathway (4)
- Regulation of actin cytoskeleton (4)
- TGF-beta signaling pathway (4)
- Vibrio cholerae infection (4)
- aspartate and glutamate metabolism (4)
- Allograft rejection (3)
- Axon guidance (3)
- Butanoate metabolism (3)
- Chronic myeloid leukemia (3)
- Dilated cardiomyopathy (3)
- ErbB signaling pathway (3)
- Fc epsilon RI signaling pathway (3)
- Fc gamma R-mediated phagocytosis (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Maturity onset diabetes of the young (3)
- Melanogenesis (3)
- NOD-like receptor signaling pathway (3)
- PPAR signaling pathway (3)
- Proteasome (3)
- Regulation of autophagy (3)
- Ribosome (3)
- Type II diabetes mellitus (3)
- beta-Alanine metabolism (3)
- Asthma (2)
- Citrate cycle (TCA cycle) (2)
- Dorso-ventral axis formation (2)
- ECM-receptor interaction (2)
- Long-term depression (2)
- Long-term potentiation (2)
- Phosphatidylinositol signaling system (2)
- Prion diseases (2)
- Systemic lupus erythematosus (2)
- Taurine and hypotaurine metabolism (2)
- Ubiquitin mediated proteolysis (2)
- Vascular smooth muscle contraction (2)
- Arachidonic acid metabolism (1)
- Arginine and proline metabolism (1)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Base excision repair (1)
- D-Glutamine and D-glutamate metabolism (1)
- Ether lipid metabolism (1)
- Glutathione metabolism (1)
- Glycerophospholipid metabolism (1)
- Glycine (1)
- Graft-versus-host disease (1)
- Hedgehog signaling pathway (1)
- Histidine metabolism (1)
- Methane metabolism (1)
- N-Glycan biosynthesis (1)
- Nitrogen metabolism (1)
- Olfactory transduction (1)
- One carbon pool by folate (1)
- Oxidative phosphorylation (1)
- Phenylalanine metabolism (1)
- Porphyrin and chlorophyll metabolism (1)
- Purine metabolism (1)
- Pyruvate metabolism (1)
- RNA degradation (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Spliceosome (1)
- Tryptophan metabolism (1)
- Tyrosine metabolism (1)
- serine and threonine metabolism (1)
